For how long should osteoporosis treatment continue?
1a KLIMAX Menopause and Osteoporosis Clinic , Vienna , Austria.
Abstract:
Studies on the most effective of the commonly used bone-specific drugs, the antiresorptives zoledronic acid and denosumab, as well as up-to-date menopausal hormone therapy for early prevention refer to sound long-term safety data. However, depending on both the patient's characteristics and the properties of the respective regimens, the rates of side-effects, tolerability and persistence differ substantially. They are crucial limiting factors for actual efficacy in the clinical setting and thus determine the length and continuation of treatment.
Related Concept Videos
Bone Remodeling
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Osteoclasts in Bone Remodeling
Pharmacokinetic–Pharmacodynamic Relationship: Duration of Dose-Effect Relationship
Pharmacokinetic–Pharmacodynamic Relationship: Influence of Elimination Half-Life on Effect Duration
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
